Katrina Thornber, Author at European Medical Journal - Page 19 of 54

Seasonal Allergy Symptoms Improved With New Biologic Treatment

The PHECDA trial evaluated stapokibart as an add-on therapy during pollen season in adults with moderate-to-severe seasonal allergic rhinitis.

EuroPCR 2025: 10-year Results of the DANAMI-3-PRIMULTI Trial

Ten-year data show complete revascularisation reduces repeat procedures in STEMI patients with multivessel disease.

EuroPCR 2025: Routine Embolic Protection Not Effective for Stroke Prevention in TAVI

Largest meta-analysis shows no reduction in stroke with routine cerebral embolic protection during TAVI procedures.

EuroPCR 2025: FFR-Guided PCI Lowers Complications After TAVI

Physiology-guided PCI halves major complications after TAVI compared to angiography alone, new FAITAVI trial data show.

EuroPCR 2025: Less Bleeding after PCI with Short DAPT and Prasugrel in Acute Coronary Syndrome

Shorter dual antiplatelet therapy followed by low-dose prasugrel cuts bleeding risk after PCI, new trial shows.

Side Effects in Bladder Cancer Treatment Worse Than Estimated

The analysis included patient-reported symptoms from treatment initiation to cycle 12 of pembrolizumab.

Cytisinicline Proves Potent and Safe for Quitting Smoking

A new Phase III trial has strengthened the evidence supporting cytisinicline as an effective and well-tolerated medication for smoking cessation.

Robotic Baby Mimics Real Feeding Behaviours for Medical Innovation

BabyBot, a soft robotic infant, mimics real feeding behaviours for safer, more realistic paediatric research and innovation.

Lanadelumab Reduces HAE Attacks in Adolescent Patients

The analysis demonstrated significant reductions in HAE attacks among adolescent patients.

Simultaneous Acne and Scar Treatment Proves More Effective

Beyond clinical outcomes, the simultaneous approach offered additional benefits: reduced overall treatment time and higher patient satisfaction.